BioSpace News Archive

The Honourable Jean-Yves Duclos, Minister of Health, announced three appointments and one reappointment to the Canadian Institutes of Health Research Governing Council.

SOLVE FSHD announced an investment of US$3 million in Altay Therapeutics; a company focused on developing lifesaving therapies by targeting disease-causing transcription factors.

The latest market analysis report published by Reports and Data, titled ‘Global Thrombocytopenia Market – Forecast to 2030,’ thoroughly examines the Thrombocytopenia industry to provide essential data & information for the targeted readers.

The global hydralazine market is expected to grow at a CAGR of 3.5% during the forecast period. The rising prevalence of hypertension and heart diseases is the major factor driving the growth of this market.

The global Multiple Sclerosis drugs market size is expected to reach USD 33.59 Billion at a steady revenue CAGR of 3.9% in 2030, according to latest analysis by Emergen Research. Increasing prevalence of the disease and technological advancements in treatments are among key factors driving growth of the market.

NKGen Biotech today announced a publication in the peer-reviewed Journal of Cancer Research and Cellular Therapeutics entitled “Durable responses using SNK01 autologous enhanced natural killer cells and pembrolizumab for chemotherapy-resistant advanced sarcoma: Case reports, review of literature, and future perspectives.”

WPD Pharmaceuticals Inc., a clinical-stage pharmaceutical company announces that the Company’s Board of Directors (the “Board”) has approved the raise of WPD Pharmaceuticals Sp. z o.o. (“WPD Poland”), the Polish subsidiary of the Company share capital from PLN 400,000 to PLN 2,100,000, that is by the amount of PLN 1,700,000, by establishment of 34,000 new, equal and indivisible shares of the nominal value of PLN 50 each and the total nominal value of PLN 1,700,000.

Defence Therapeutics Inc., a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report that Defence’s novel vaccine candidate triggers a potent anti-tumoral response capable of curing animals with pre-established lymphoma.

The latest market analysis report published by Reports and Data, titled ‘Global Presbyopia Treatment Market – Forecast to 2030,’ thoroughly examines the Presbyopia Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Sezary Syndrome Treatment Market – Forecast to 2030,’ thoroughly examines the Sezary Syndrome Treatment industry to provide essential data & information for the targeted readers.